✦ LIBER ✦

Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study

✍ Scribed by Richard Appleton; Klaus Fichtner; Linda LaMoreaux; Jeannine Alexander; Stephen Maton; Guta Murray; Elizabeth Garofalo

Book ID: 111129392
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 109 KB
Volume: 43
Category: Article
ISSN: 0012-1622
DOI: 10.1111/j.1469-8749.2001.tb00201.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gabapentin as Add-On Therapy in Children

Gabapentin as Add-On Therapy in Children with Refractory Partial Seizures: A 12-Week, Multicentre, Double-Blind, Placebo-Controlled Study

✍ Richard Appleton; Klaus Fichtner; Linda LaMoreaux; Jeannine Alexander; Gwyneth H 📂 Article 📅 1999 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 671 KB

Long-term safety and efficacy of gabapen

Long-term safety and efficacy of gabapentin (neurontin) as add-on therapy in patients with refractory partial seizures

✍ Henning Anhut; Philip J Ashman; Thomas J Feuerstein; Erhard Quebe-Fehling; Maria 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 588 KB

An open-label, add-on study of pregabali

An open-label, add-on study of pregabalin in patients with partial seizures: A multicenter trial in Greece

✍ Stefanos Tsounis; Vasilios K. Kimiskidis; Dimitrios Kazis; Konstantinos Gkiatas; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Multicenter Double-Blind, Randomized, Pl

Multicenter Double-Blind, Randomized, Placebo-Controlled Trial of Levetiracetam as Add-On Therapy in Patients with Refractory Partial Seizures

✍ Simon D. Shorvon; Armand Löwenthal; Dieter Janz; Edith Bielen; Pierre Loiseau; f 📂 Article 📅 2000 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 672 KB

Long-term evaluation of the efficacy and

Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-up

✍ T. Rentmeester; A. Janssen; J. Hulsman; F. Scholtes; B. van der Kleij; J. Overwe 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 534 KB

The effect and safety of loreclezole were evaluated during a long-term follow-up trial targeting higher plasma concentrations than those of the preceding controlled trial. The result is better than in the double-blind trial, in which loreclezole doses were administered to reach plasma concentrations